Skip to content

AdaptHealth AHCO Goodwill impairment

Discontinued — last reported Q4 '25

Goodwill impairment at other companies

Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$0

Segments

By segment

See full
Diabetes Health$128M
Respiratory Health$0
Sleep Health$0
Wellness at Home$0

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.4%
Enterprise value$3.32B+4.2%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: AdaptHealth’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's goodwill impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's goodwill impairment?
AdaptHealth (AHCO) reported goodwill impairment of $128M in Q4 2025.
What does goodwill impairment mean?
Write-down of goodwill carrying value when a reporting unit's fair value falls below its book value, indicating that past acquisitions have lost value.